(PO22-04-22) Effect of Moringa Oliefera Supplementation During Pregnancy on Nutritional Status in Children 2–5 Years Old in Indonesia: A-Follow-Up Study

The ePoster content is available to NUTRITION 2022 LIVE ONLINE attendees who are logged in.<br><br>If you are registered, log in and then come back here to use this button.

Presenting Author(s)

Hasan Basri, Dr (cand)
– Visiting Scholar, Cornell University, Makassar, Sulawesi Selatan, Indonesia

Co-Author(s)

AA

Ansariadi Ansariadi
– Hasanuddin University
VH

Veni Hadju, Professor
– Hasanuddin University
SH

Siti Helmiyanti
– Gajah Mada University
RI

Rahayu Indriasari
– Hasanuddin University
RR

Rahayu Reski
– Hasanuddin University
SS

Stang Stang
– Hasanuddin University
AS

Aminuddin Syam
– Hasanuddin University
AZ

Andi Zulkifli, Professor
– Hasanuddin University

Disclosure(s):

Hasan Basri, Dr (cand): No relevant financial relationship(s) with ineligible companies to disclose.

Objectives: o examine the effects of prenatal Moringa oliefera extract (EG) or powder (PG), compared to iron-folic acid (IFA) supplementation during pregnancy on nutritional status of children aged 2-5 years in Indonesia.

Methods: Participants were children (2-5 y) born to pregnant women who participated in a randomized controlled trial. In the parent trial, pregnant women were randomized to receive Moringa oliefera extract (EG) or powder (PG), or iron-folic acid (IFA), twice weekly during pregnancy beginning in the third trimester. Capillary blood samples were collected in children lby a trained phlebotomist. Whole blood samples were analyzed for hemoglobin (Hb) via portable hemoglobinometer (HemoCue Hb 201+ analyser, Helsinborg, Sweden). Hepcidin concentrations were measured by ELISA (ELISA Technique, BT LAB, Shanghai, China) and lactic acid was measured via RT-PCR. Anemia was defined as hemoglobin concentrations of < 11.0 g/dL. Height-for-age (HAZ) Z-scores were calculated using the World Health Organization (WHO) Child Growth Standards and used to define stunting (HAZ < -2 SD). Multivariate analyses were conducted to determine the effect of a the interventions on outcomes.

Results: The prevalence of stunting at baseline in EG was 42 (28.8) lower than PG and IFA [59 (40.4) and 45 (30.8)]. The prevalence of stunting (HAZ < -2) was lower at each time point (i.e., 2-3y; 3-4y; 4-5y) during follow-up in the EG group, compared to PG or IFA groups (p < 0.05), and the number of stunted cases significantly decreased during follow-up in the EG group, compared to the PG or IFA groups (p < 0.05). The quantity of lactobacillus lactic acid bacteria was significantly higher in the EG group compared to the other groups at 2-3y (6.88 log CFU/gram vs. 6.57; 5.94 log CFU/gram; p< 0.05). Hepcidin concentrations were significantly higher in EG groups than PG or IFA (1.85 ng/mL vs 1.38; 0.9 ng/mL, although there were no differences in hemoglobin concentrations between intervention groups.

Conclusions: Findings suggest that Moringa oleifera extract supplementation during pregnancy was associated with lower prevalence of stunting in children in this population.

Funding Sources: Funding in research is supported by Directorate General of Higher Education, Research, and Technology, Ministry of Education, Culture, Research, and Technology of the Republic of Indonesia.